![Ben Sattelle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Ben Sattelle
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
C4X Discovery Ltd.
![]() C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ben Sattelle
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Oxford | College/University | Doctorate Degree | |
The University of Manchester | College/University | Doctorate Degree | |
The University of Edinburgh | College/University | Undergraduate Degree | |
C4X DISCOVERY HOLDINGS PLC | Pharmaceuticals: Major | Founder Founder | |
Imperagen Ltd.
![]() Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Vereinigtes Königreich | 5 |
Israel | 2 |
Sektoral
Consumer Services | 4 |
Health Technology | 2 |
Commercial Services | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Founder | 4 |
Director/Board Member | 3 |
Doctorate Degree | 2 |
President | 1 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Ben Sattelle
- Unternehmensverbindungen